Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Policy
A bill introduced by Sen. Michael F. Bennet (D-Colo.) would give new authority to FDA to ensure drug quality. Among other provisions, the Drug Safety & Accountability Act of 2010 gives FDA additional recall powers, allows the agency to require companies to increase oversight of overseas suppliers, and gives it new authority to assess penalties. The bill has the support of the Bulk Pharmaceuticals Task Force, an affiliate of the Society of Chemical Manufacturers & Affiliates. “About 80% of active drug ingredients come from overseas, yet they receive less than 5% of FDA’s resources,” said the task force’s chairman, Brant Zell, vice president of Cherokee Pharmaceuticals, in a statement. “This bill is a good starting point in giving FDA the resources to help ensure a safer U.S. drug supply.”
This article has been sent to the following recipient: